Bi-allelic Variants in DAP3 Result in Reduced Assembly of the Mitoribosomal Small Subunit with Altered Apoptosis and a Perrault-syndrome-spectrum Phenotype

The mitochondrial ribosome (mitoribosome) synthesizes 13 protein subunits of the oxidative phosphorylation system encoded by the mitochondrial genome. The mitoribosome is composed of 12S rRNA, 16S rRNA, and 82 mitoribosomal proteins encoded by nuclear genes. To date, variants in 12 genes encoding mitoribosomal proteins are associated with rare monogenic disorders and frequently show combined oxidative phosphorylation deficiency. Here, we describe five unrelated individuals with bi-allelic variants in death-associated protein 3 (DAP3), a nuclear gene encoding mitoribosomal small subunit 29 (MRPS29), with variable clinical presentations ranging from Perrault syndrome (sensorineural hearing loss and ovarian insufficiency) to an early childhood neurometabolic phenotype. Assessment of respiratory-chain function and proteomic profiling of fibroblasts from affected individuals demonstrated reduced MRPS29 protein amounts and, consequently, decreased levels of additional protein components of the mitoribosomal small subunit, as well as an associated combined deficiency of complexes I and IV. Lentiviral transduction of fibroblasts from affected individuals with wild-type DAP3 cDNA increased DAP3 mRNA expression and partially rescued protein levels of MRPS7, MRPS9, and complex I and IV subunits, demonstrating the pathogenicity of the DAP3 variants. Protein modeling suggested that DAP3 disease-associated missense variants can impact ADP binding, and in vitro assays demonstrated that DAP3 variants can consequently reduce both intrinsic and extrinsic apoptotic sensitivity, DAP3 thermal stability, and DAP3 GTPase activity. Our study presents genetic and functional evidence that bi-allelic variants in DAP3 result in a multisystem disorder of combined oxidative phosphorylation deficiency with pleiotropic presentations, consistent with mitochondrial dysfunction.

References

Han J, An O, Ren X, Song Y, Tang S, Shen H . Multilayered control of splicing regulatory networks by DAP3 leads to widespread alternative splicing changes in cancer. Nat Commun. 2022; 13(1):1793. PMC: 8980049. DOI: 10.1038/s41467-022-29400-7. View

Harada T, Iwai A, Miyazaki T . Identification of DELE, a novel DAP3-binding protein which is crucial for death receptor-mediated apoptosis induction. Apoptosis. 2010; 15(10):1247-55. DOI: 10.1007/s10495-010-0519-3. View

Di Nottia M, Marchese M, Verrigni D, Mutti C, Torraco A, Oliva R . A homozygous MRPL24 mutation causes a complex movement disorder and affects the mitoribosome assembly. Neurobiol Dis. 2020; 141:104880. DOI: 10.1016/j.nbd.2020.104880. View

Tang T, Zheng B, Chen S, Murphy A, Kudlicka K, Zhou H . hNOA1 interacts with complex I and DAP3 and regulates mitochondrial respiration and apoptosis. J Biol Chem. 2008; 284(8):5414-24. PMC: 2643507. DOI: 10.1074/jbc.M807797200. View

Kim H, Chae H, Thomas M, Miyazaki T, Monosov A, Monosov E . Mammalian dap3 is an essential gene required for mitochondrial homeostasis in vivo and contributing to the extrinsic pathway for apoptosis. FASEB J. 2006; 21(1):188-96. DOI: 10.1096/fj.06-6283com. View

Menezes M, Guo Y, Zhang J, Riley L, Cooper S, Thorburn D . Mutation in mitochondrial ribosomal protein S7 (MRPS7) causes congenital sensorineural deafness, progressive hepatic and renal failure and lactic acidemia. Hum Mol Genet. 2015; 24(8):2297-307. DOI: 10.1093/hmg/ddu747. View

van der Ven A, Cabrera-Orefice A, Wente I, Feichtinger R, Tsiakas K, Weiss D . Expanding the phenotypic and biochemical spectrum of NDUFAF3-related mitochondrial disease. Mol Genet Metab. 2023; 140(3):107675. DOI: 10.1016/j.ymgme.2023.107675. View

Gardeitchik T, Mohamed M, Ruzzenente B, Karall D, Guerrero-Castillo S, Dalloyaux D . Bi-allelic Mutations in the Mitochondrial Ribosomal Protein MRPS2 Cause Sensorineural Hearing Loss, Hypoglycemia, and Multiple OXPHOS Complex Deficiencies. Am J Hum Genet. 2018; 102(4):685-695. PMC: 5985281. DOI: 10.1016/j.ajhg.2018.02.012. View

Tucker E, Rius R, Jaillard S, Bell K, Lamont P, Travessa A . Genomic sequencing highlights the diverse molecular causes of Perrault syndrome: a peroxisomal disorder (PEX6), metabolic disorders (CLPP, GGPS1), and mtDNA maintenance/translation disorders (LARS2, TFAM). Hum Genet. 2020; 139(10):1325-1343. DOI: 10.1007/s00439-020-02176-w. View

10.

Bakhshalizadeh S, Hock D, Siddall N, Kline B, Sreenivasan R, Bell K . Deficiency of the mitochondrial ribosomal subunit, MRPL50, causes autosomal recessive syndromic premature ovarian insufficiency. Hum Genet. 2023; 142(7):879-907. PMC: 10329598. DOI: 10.1007/s00439-023-02563-z. View

11.

Miyazaki T, Reed J . A GTP-binding adapter protein couples TRAIL receptors to apoptosis-inducing proteins. Nat Immunol. 2001; 2(6):493-500. DOI: 10.1038/88684. View

12.

Cavdar Koc E, Ranasinghe A, Burkhart W, Blackburn K, Koc H, Moseley A . A new face on apoptosis: death-associated protein 3 and PDCD9 are mitochondrial ribosomal proteins. FEBS Lett. 2001; 492(1-2):166-70. DOI: 10.1016/s0014-5793(01)02250-5. View

13.

Demain L, Antunes D, OSullivan J, Bhaskhar S, OKeefe R, Newman W . A known pathogenic variant in the essential mitochondrial translation gene RMND1 causes a Perrault-like syndrome with renal defects. Clin Genet. 2018; 94(2):276-277. DOI: 10.1111/cge.13255. View

14.

Ferrari A, DelOlio S, Barrientos A . The Diseased Mitoribosome. FEBS Lett. 2020; 595(8):1025-1061. PMC: 8278227. DOI: 10.1002/1873-3468.14024. View

15.

Hochberg I, Demain L, Richer J, Thompson K, Urquhart J, Rea A . Bi-allelic variants in the mitochondrial RNase P subunit PRORP cause mitochondrial tRNA processing defects and pleiotropic multisystem presentations. Am J Hum Genet. 2021; 108(11):2195-2204. PMC: 8595931. DOI: 10.1016/j.ajhg.2021.10.002. View

16.

Itoh Y, Singh V, Khawaja A, Naschberger A, Nguyen M, Rorbach J . Structure of the mitoribosomal small subunit with streptomycin reveals Fe-S clusters and physiological molecules. Elife. 2022; 11. PMC: 9731571. DOI: 10.7554/eLife.77460. View

17.

Zech M, Kopajtich R, Steinbrucker K, Bris C, Gueguen N, Feichtinger R . Variants in Mitochondrial ATP Synthase Cause Variable Neurologic Phenotypes. Ann Neurol. 2021; 91(2):225-237. PMC: 9939050. DOI: 10.1002/ana.26293. View

18.

Plagnol V, Curtis J, Epstein M, Mok K, Stebbings E, Grigoriadou S . A robust model for read count data in exome sequencing experiments and implications for copy number variant calling. Bioinformatics. 2012; 28(21):2747-54. PMC: 3476336. DOI: 10.1093/bioinformatics/bts526. View

19.

Maiti P, Lavdovskaia E, Barrientos A, Richter-Dennerlein R . Role of GTPases in Driving Mitoribosome Assembly. Trends Cell Biol. 2021; 31(4):284-297. PMC: 7954922. DOI: 10.1016/j.tcb.2020.12.008. View

20.

Bohnsack M, Sloan K . The mitochondrial epitranscriptome: the roles of RNA modifications in mitochondrial translation and human disease. Cell Mol Life Sci. 2017; 75(2):241-260. PMC: 5756263. DOI: 10.1007/s00018-017-2598-6. View